The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives.

Burden, A D; Warren, R B; Kleyn, C E; McElhone, K; Smith, C H; Reynolds, N J; Ormerod, A D; Griffiths, C E M

Burden, A D; Warren, R B; Kleyn, C E; McElhone, K; Smith, C H; Reynolds, N J; Ormerod, A D; Griffiths, C E M.

Affiliation

Burden AD; Department of Dermatology, Western Infirmary, Glasgow G11 6NT, UK. david.burden@glasgow.ac.uk

Br J Dermatol ; 166(3): 545-54, 2012 Mar.

Article in En | MEDLINE | ID: mdl-22356636

Subject(s)

Biological Products/adverse effects; Dermatologic Agents/adverse effects; Pharmacovigilance; Psoriasis/drug therapy; Registries; Adverse Drug Reaction Reporting Systems; Data Collection; Dermatology; Humans; Ireland; Organizational Objectives; Patient Safety; Patient Selection; Risk Factors; Societies, Medical; United Kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Psoriasis / Biological Products / Registries / Dermatologic Agents / Pharmacovigilance Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Br J Dermatol Year: 2012 Type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google